產(chǎn)品詳情
簡(jiǎn)單介紹:
Altiratinib
詳情介紹:
Purpose | A highly potent inhibitor of MET, TIE2, VEGFR2 and TRK kinases |
Characteristics | Altiratinib is a selective and highly potent inhibitor of MET, TIE2, VEGFR2 and TRK kinases with potential anticancer activity. It effectively reduces tumor burden in vivo and blocks c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with a HGF antagonist in vitro. Through its balanced inhibitory potency versus MET, TIE2, and VEGFR2, altiratinib inhibits three major evasive (re)vascularization and resistance pathways (HGF, ANG, and VEGF) and blocks tumor invasion and metastasis. Displays blood-brain barrier penetration. |
Purity | ≥ 98?% by HPLC |
Chemical Name | N-(4-((2-(cyclopropanecarboxamido)pyridin-4-yl)oxy)-2,5-difluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; DCC-2701 |
Formula | C??H??F?N?O? |
Permeability | Cell-permeable |
Solubility | DMSO (>30 mg/ml) |
Molecular Weight | 510.46 g/mol |
CAS-No | 1345847-93-9 |
Restrictions | For Research Use only |
Format | Solid |
Handling Advice | Protect from air and light |
Storage | -20 °C |
Expiry Date | 36 months |